EANO guideline on the diagnosis and management of meningiomas

R Goldbrunner, P Stavrinou, MD Jenkinson… - Neuro …, 2021 - academic.oup.com
Meningiomas are the most common intracranial tumors. Yet, only few controlled clinical trials
have been conducted to guide clinical decision making, resulting in variations of …

[HTML][HTML] Meningioma: a review of epidemiology, pathology, diagnosis, treatment, and future directions

C Ogasawara, BD Philbrick, DC Adamson - Biomedicines, 2021 - mdpi.com
Meningiomas are the most common intracranial tumor, making up more than a third of all
primary central nervous system (CNS) tumors. They are mostly benign tumors that can be …

An overview of meningiomas

RA Buerki, CM Horbinski, T Kruser, PM Horowitz… - Future …, 2018 - Taylor & Francis
Meningiomas are the most common primary intracranial tumor. Important advances are
occurring in meningioma research. These are expected to accelerate, potentially leading to …

EANO guidelines for the diagnosis and treatment of meningiomas

R Goldbrunner, G Minniti, M Preusser… - The Lancet …, 2016 - thelancet.com
Although meningiomas are the most common intracranial tumours, the level of evidence to
provide recommendations for the diagnosis and treatment of meningiomas is low compared …

Meningiomas

A Perry - Practical surgical neuropathology: a diagnostic …, 2018 - Elsevier
Accounting for over a third of all primary CNS neoplasms, meningiomas are amongst the
most common diagnoses encountered in neurosurgical practice. Like their non-neoplastic …

[HTML][HTML] Signaling pathways in brain tumors and therapeutic interventions

S Li, C Wang, J Chen, Y Lan, W Zhang… - … and Targeted Therapy, 2023 - nature.com
Brain tumors, although rare, contribute to distinct mortality and morbidity at all ages.
Although there are few therapeutic options for brain tumors, enhanced biological …

Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas

I Maggio, E Franceschi, A Tosoni, VD Nunno… - CNS …, 2021 - Taylor & Francis
Meningiomas are the most common primary intracranial tumors. The majority of
meningiomas are benign, but they can present different grades of dedifferentiation from …

Current treatment options for meningioma

C Apra, M Peyre, M Kalamarides - Expert review of …, 2018 - Taylor & Francis
Introduction: With an annual incidence of 5/100,000, meningioma is the most frequent
primary tumor of the central nervous system. Risk factors are radiotherapy and hormone …

Advances in meningioma genetics: novel therapeutic opportunities

M Preusser, PK Brastianos, C Mawrin - Nature Reviews Neurology, 2018 - nature.com
Meningiomas currently are among the most frequent intracranial tumours. Although the
majority of meningiomas can be cured by surgical resection,∼ 20% of patients have an …

Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539

L Rogers, P Zhang, MA Vogelbaum, A Perry… - Journal of …, 2017 - thejns.org
OBJECTIVE This is the first clinical outcomes report of NRG Oncology RTOG 0539, detailing
the primary endpoint, 3-year progression-free survival (PFS), compared with a predefined …